Prognostic Model Research

  Prognosis Research Strategy (PROGRESS) 3: prognostic model research - PubMed

2013

Review PLoS Med

. 2013;10(2):e1001381. doi: 10.1371/journal.pmed.1001381. Epub 2013 Feb 5.

Prognosis Research Strategy (PROGRESS) 3: prognostic model research

https://pubmed.ncbi.nlm.nih.gov/23393430/

Prognostic models are abundant in the medical literature yet their use in practice seems limited. In this article, the third in the PROGRESS...

###

https://pubmed.ncbi.nlm.nih.gov/23386361/

BMJ

. 2013 Feb 5;346:e5793. doi: 10.1136/bmj.e5793.

Prognosis research strategy (PROGRESS) 4: stratified medicine research

From Twitter  Maarten van Smeden

https://twitter.com/MaartenvSmeden/status/1371829584249905152

https://www.slideshare.net/MaartenvanSmeden/development-and-evaluation-of-prediction-models-pitfalls-and-solutions

March 2021

#####

114 slide deck

Similar 100 slide deck by Ben Van Calster  March 2021

https://www.slideshare.net/BenVanCalster/development-and-evaluation-of-prediction-models-pitfalls-and-solutions-part-ii?qid=3f3d5590-2402-4ddf-8803-b119e965a9b9&v=&b=&from_search=1

(from TWITTER)

"08 PREDICTIVE 04 PREDICTIVE"

Clipped from: https://twitter.com/maartenvsmeden/status/1372111094815277060?s=12

Above slide is #51 in his deck 2021 03 Van Smelden....pdf

tiny print says 'courtesy (someone) no further ref'  LAURE WYNANTS

https://twitter.com/laure_wynants?lang=en

https://www.linkedin.com/in/laure-wynants/?originalSubdomain=be

https://twitter.com/maartenvsmeden/status/1372106090108837890

####

ALLELICA wants polygenic risk scores

https://www.genomeweb.com/informatics/allelica-wants-polygenic-risk-scores-become-routine-heart-disease-care#.YFfow69KhPY

CONSERVATIVE RE MAAA

Molecular Biomarker Testing in Localized Prostate Cancer

Baraban et al

APLM 145_264

https://meridian.allenpress.com/aplm/article/145/3/264/449935/Molecular-Biomarker-Testing-in-Localized-Prostate

POSITIVE RE MAAA

https://jamanetwork.com/journals/jamaoncology/fullarticle/2776221

Invited Commentary

February 11, 2021

Deciphering Genomic Risk in Prostate Cancer—Ready for Prime Time

Sean E. McGuire, MD, PhD1,2

https://jamanetwork.com/journals/jamaoncology/fullarticle/2776225

Original Investigation

February 11, 2021

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial

Felix Y. Feng, MD1,2,3; Huei-Chung Huang, MA4; Daniel E. Spratt, MD5; et al

MEDPAGE

https://www.medpagetoday.com/hematologyoncology/prostatecancer/91156

PRESS Feb 11 2021

https://www.prnewswire.com/news-releases/decipher-test-clinically-validated-as-a-predictor-of-overall-survival-in-men-with-prostate-cancer-301227328.html

presS may 2024

https://www.prnewswire.com/news-releases/nccn-guidelines-designate-decipher-prostate-as-recommended-for-men-with-adverse-pathology-after-radical-prostatectomy-301028637.html#:~:text=About%20Decipher%20Prostate%20RP%20and%20Decipher%20GRID&text=The%20Decipher%20score%20is%20intended,and%20can%20reduce%20treatment%20intensity.

NCCN Guidelines Designate Decipher Prostate as "Recommended" for Men with Adverse Pathology after Radical Prostatectomy

The first and only genomic test to achieve "Recommended" status for the management of prostate cancer patients

 Decipher Biosciences (PRNewsfoto/Decipher Biosciences )

NEWS PROVIDED BY

Decipher Biosciences 

Mar 24, 2020, 07:00 ET